Advances of anti-inflammatory cytokines in multiple sclerosis
WANG Dan
WANG Zhe
LIU Libo
LI Yuyuan
Abstract：Multiple sclerosis is the most common inflammatory demyelinating disease of the central nervous system. At present, its etiology and pathogenesis are unclear, and its treatment is also limited. Anti-inflammatory cytokines are involved in the generation of immunotolerance, and can protect the host during immune responses. Rational understanding of the immunoregulatory mecha-nisms will have a considerable effect on pathogenesis and drug therapy for multiple sclerosis.
Keywords：Multiple sclerosisAnti-inflammatory cytokinesPathogenesisDrug therapy
Publication Date：2016-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 158-161 )